ReviewDrug design, development and therapy2019

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date.

Renaud Felten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.